Fenben lab fenbendazol is an animal anthelmintic (dewormer) in the broad-spectrum benzimidazole carbamate family of anthelmintics. It is effective against a variety of parasites including roundworms, hookworms, whipworms, the tapeworm genus Taenia (but not Dipylidium caninum) and pinworms. Fenbendazole can also be used to treat capillaria in pet poultry but should not be given to poultry during periods of growth or molting because it can cause feather loss by halting cell division. It is a safe drug for long term use in humans and has a track record of safety for veterinary and human use dating back to 1976.
Fenbendazole, or FBZ, is a cheap and readily available anti-parasitic drug commonly used in veterinary medicine. It belongs to the benzimidazole family of drugs, which are broad-spectrum anthelmintics that have been safely in use as dewormers for nearly six decades. The benzimidazoles are able to destroy parasitic worms by disrupting microtubules, the structures that bind together inside cells and allow them to move and divide rapidly. It has recently been discovered that fenbendazole also acts as an effective antineoplastic agent by targeting the growth of cancer cells.
Studies have shown that fenbendazole targets cancer cells and decreases tumor size by blocking their ability to take up glucose, which is the primary energy source for fast-growing cancers. It can work as a standalone treatment or alongside conventional chemotherapy, and has been found to increase the effectiveness of these treatments. Unlike many other chemotherapy agents, fenbendazole does not damage healthy cells.
A recent study tested a combination of fenbendazole and the natural compound quercetin, which has been proven to be effective against cancer cell growth. The fenbendazole prevented the cancer cells from taking up glucose, and quercetin increased the production of a gene that p53 (a gene that is mutated in many cancer patients) activates to kill cancer cells. In xenograft experiments, the fenbendazole and quercetin treatment significantly decreased tumor size in mice with lymphoma and other cancers.
Although the results of this research are encouraging, more research and substantial evidence is needed before fenbendazole can be used to treat cancer in humans. In the meantime, a vitamin-rich diet in conjunction with fenbendazole may be beneficial to cancer patients.
Several anecdotal stories on various websites have been published describing success using fenbendazole for cancer. However, it is important to understand that these stories are anecdotal and not scientifically supported. It is important to discuss the possibility of incorporating this medication into your treatment plan with your doctor. fenben lab fenbendazol